iRhythm Technologies (IRTC, Financial) has recently been the subject of an analyst report by Morgan Stanley. The firm maintained its current "Overweight" rating on the stock, signaling a positive outlook despite a lowered price target.
According to the report dated July 15, 2025, analyst Cecilia Furlong from Morgan Stanley adjusted the price target for iRhythm Technologies (IRTC, Financial) from $160.00 USD down to $147.00 USD. This adjustment represents a change of -8.12% from the previous target.
The decision to maintain the "Overweight" rating reflects Morgan Stanley's continued confidence in iRhythm Technologies' (IRTC, Financial) potential. Despite the lowered price target, the rating suggests that the firm believes the stock will outperform relative to its sector peers.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 11 analysts, the average target price for iRhythm Technologies Inc (IRTC, Financial) is $146.00 with a high estimate of $167.00 and a low estimate of $130.00. The average target implies an upside of 5.10% from the current price of $138.91. More detailed estimate data can be found on the iRhythm Technologies Inc (IRTC) Forecast page.
Based on the consensus recommendation from 13 brokerage firms, iRhythm Technologies Inc's (IRTC, Financial) average brokerage recommendation is currently 1.6, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for iRhythm Technologies Inc (IRTC, Financial) in one year is $167.39, suggesting a upside of 20.5% from the current price of $138.91. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the iRhythm Technologies Inc (IRTC) Summary page.
